Cargando…

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Several COVID-19 vaccines have shown good efficacy in clinical trials, but there remains uncertainty about the efficacy of vaccines against different variants. Here, we investigate the efficacy of ChAdOx1 nCoV-19 (AZD1222) against symptomatic COVID-19 in a post-hoc exploratory analysis of a Phase 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clemens, Sue Ann Costa, Folegatti, Pedro M., Emary, Katherine R. W., Weckx, Lily Yin, Ratcliff, Jeremy, Bibi, Sagida, De Almeida Mendes, Ana Verena, Milan, Eveline Pipolo, Pittella, Ana, Schwarzbold, Alexandre V., Sprinz, Eduardo, Aley, Parvinder K., Bonsall, David, Fraser, Christophe, Fuskova, Michelle, Gilbert, Sarah C., Jenkin, Daniel, Kelly, Sarah, Kerridge, Simon, Lambe, Teresa, Marchevsky, Natalie G., Mujadidi, Yama F., Plested, Emma, Ramasamy, Maheshi N., Simmonds, Peter, Golubchik, Tanya, Voysey, Merryn, Pollard, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494913/ https://www.ncbi.nlm.nih.gov/pubmed/34615860 http://dx.doi.org/10.1038/s41467-021-25982-w

Ejemplares similares

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
por: Marchevsky, Natalie Gabrielle, et al.
Publicado: (2022)

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
por: Flaxman, Amy, et al.
Publicado: (2021)

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults
por: Costa Clemens, Sue Ann, et al.
Publicado: (2023)

Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials
por: Voysey, Merryn, et al.
Publicado: (2023)

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
por: Feng, Shuo, et al.
Publicado: (2021)

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
por: Emary, Katherine R W, et al.
Publicado: (2021)

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
por: Barrett, Jordan R., et al.
Publicado: (2021)

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
por: Ramasamy, Maheshi N, et al.
Publicado: (2020)

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
por: Li, Grace, et al.
Publicado: (2022)

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
por: Voysey, Merryn, et al.
Publicado: (2021)

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
por: Folegatti, Pedro M, et al.
Publicado: (2020)

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
por: Voysey, Merryn, et al.
Publicado: (2021)

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
por: Frater, John, et al.
Publicado: (2021)

Nasopharyngeal Carriage of Pneumococcus in Children in England up to 10 Years After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Persistence of Serotypes 3 and 19A and Emergence of 7C
por: Tiley, Karen S, et al.
Publicado: (2022)

Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR
por: Ratcliff, Jeremy, et al.
Publicado: (2022)

Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers
por: McCullagh, David, et al.
Publicado: (2015)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
por: Ogbe, Ane, et al.
Publicado: (2022)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
por: Voysey, Merryn, et al.
Publicado: (2020)

Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model
por: Gibani, Malick M., et al.
Publicado: (2020)

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
por: Costa Clemens, Sue Ann, et al.
Publicado: (2022)

Mixed effects approach to the analysis of the stepped wedge cluster randomised trial - accounting for the confounding effect of time
por: Nickless, Alecia, et al.
Publicado: (2015)

Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials
por: Bendor-Samuel, Owen Martyn, et al.
Publicado: (2023)

Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus
por: Fidler, Sarah, et al.
Publicado: (2022)

Assessing sex-differences and the effect of timing of vaccination on immunogenicity, reactogenicity and efficacy of vaccines in young children: study protocol for an individual participant data meta-analysis of randomised controlled trials
por: Voysey, Merryn, et al.
Publicado: (2016)

Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates
por: Voysey, Merryn, et al.
Publicado: (2017)

The Design and Analysis of Seroefficacy Studies for Typhoid Conjugate Vaccines
por: Liu, Xinxue, et al.
Publicado: (2019)

Computing threshold antibody levels of protection in vaccine clinical trials: An assessment of methodological bias
por: Voysey, Merryn, et al.
Publicado: (2018)

An Appraisal of the Clinical Features of Pediatric Enteric Fever: Systematic Review and Meta-analysis of the Age-Stratified Disease Occurrence
por: Britto, Carl, et al.
Publicado: (2017)

‘Be on the TEAM’ Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents
por: Carr, Jeremy, et al.
Publicado: (2020)

Optimising DTwP-containing vaccine infant immunisation schedules (OptImms) — a protocol for two parallel, open-label, randomised controlled trials
por: Kelly, Sarah, et al.
Publicado: (2023)

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
por: Liu, Xinxue, et al.
Publicado: (2021)

Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment
por: Folegatti, Pedro M, et al.
Publicado: (2022)

Mixed effects approach to the analysis of the stepped wedge cluster randomised trial—Investigating the confounding effect of time through simulation
por: Nickless, Alecia, et al.
Publicado: (2018)

Diagnostic accuracy of Fever-PAIN and Centor criteria for bacterial throat infection in adults with sore throat: a secondary analysis of a randomised controlled trial
por: Seeley, Anna, et al.
Publicado: (2021)

Logistics of Implementing a Large-scale Typhoid Vaccine Trial in Kathmandu, Nepal
por: Colin-Jones, Rachel, et al.
Publicado: (2019)

Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial
por: Theiss-Nyland, Katherine, et al.
Publicado: (2019)

Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial
por: Theiss-Nyland, Katherine, et al.
Publicado: (2019)

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
por: Shaw, Robert H, et al.
Publicado: (2022)

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines
por: Shaw, Robert H., et al.
Publicado: (2023)

Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences
por: Voysey, Merryn, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ptb12d6344ookhi1q3e4s501gq